The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris

About this trial

The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients ⩾ 18 years;

Diagnosed as spondyloarthritis (SpA) according ASAS classification;

Affiliated to a social security scheme;

Have signed the written informed consent form.

Disqualifiers

Subjects unable to understand the proposed study and/or sign a informed consent form;

Pregnant women or breast feeding women;

Subjects under guardianship or curatorship;

Have taken antibiotic 1 month prior to inclusion;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Biopsy

    Procedure/Surgery

    Biopsy during recto-coloscopy

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: SPA patientActive comparator 1 intervention
Group B: Subject without SPASham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Isolation and characterization of R. gnavus

Isolation and characterization of R. gnavus bacterium from intestinal biopsy.

Time frame
At the end of study, up to 2 years
2

Bacteria analysis

Analysis of repartition of R. gnavus bacterium in each group and the comparison between 2 groups.

Time frame
At the end of study, up to 2 years

Secondary outcomes

1

Bacterial strain's abundance

Compare the abundance by RT-q-PCR of bacterial strain (R. gnavus) between mucus biopsy sampling and faecal sampling, collected from PCR patients or control subjects respectively.

Time frame
At the end of study, up to 2 years
2

Mucin-degradation of Ruminococcus gnavus

Study the ability of the strain to grow on mucins of intestinal biopsy, colored after fixation to carnoy.

Time frame
At the end of study, up to 2 years
3

RNA sequencing analysis of biopsy

RNA sequencing analysis of rectal biopsy between SPA patients and control subjects.

Time frame
At the end of study, up to 2 years
4

Interaction between bacteria and intestinal epithelial cells

In order to study the interaction between bacteria and intestinal epithelial cells in culture (organoids). Study the induction of several target genes as peptides anti-microbians, mucin or chemokines by RT-q-PCR.

Time frame
At the end of study, up to 2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.